参考文献/References:
[1] Meschia J F, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(12): 3754-832.
[2] Aguilar M I, Freeman W D. Spontaneous intracerebral hemorrhage[J]. Semin Neurol, 2010, 30(05): 555-64.
[3] GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol,2021, 20(10): 795-820.
[4] 王拥军,李子孝,谷鸿秋,等.中国卒中报告2020(中文版)[J].中国卒中杂志,2022,17(05):433-447.
[5] 王陇德,彭斌,张鸿祺,等.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志,2022,19(02):136-144.
[6] 马丽媛,王增武,樊静,等.《中国心血管健康与疾病报告2022》要点解读[J].中国全科医学,2023,26(32):3975-3994.
[7] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》要点解读[J].中国心血管杂志,2024,29(04):305-324.
[8] Institute for Health Metrics and Evaluation (IHME). Global Brain Health Spending 2000-2019[DB/OL]. (2025-04-29)[2025-06-03].https://ghdx.healthdata.org/record/ihme-data/global-brain-health-spending-2000-2019.
[9] 于洗河,高尚,贾欢欢,等.1999年、2009年、2019年我国与全球脑卒中疾病负担研究[J].中国卫生经济,2021,40(06):58-61.
[10] 付祥锐,朱广涵,田文心,等.1990—2019年中国居民脑卒中及其危险因素疾病负担变化趋势分析[J].中国公共卫生,2025,41(03):257-262.
[11] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(09):666-682.
[12] 郝广志,董玉书,张冰莹,等.1990至2021年全球中年人群缺血性脑卒中发病趋势及年龄-时期-队列模型分析[J].中华神经外科疾病研究杂志,2024,18(06):8-14.
[13] 张玉,李咏梅,陆慧萍,等.2002—2023年上海市松江区脑卒中疾病负担变化分析[J].中国慢性病预防与控制,2024,32(09):717-720.
[14] 汤少梁,赵兴华,董慧秋,等.中国、美国和全球居民2010—2019年脑卒中疾病负担趋势年龄-时期-队列分析[J].中国公共卫生,2024,40(06):649-658.
[15] O'Donnell M J, Chin S L, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries(interstrpke): a case-control study[J]. Lancet, 2016, 388(10046): 761-775.
[16] 孙铭繁,倪文庆,袁雪丽,等.深圳市福田区慢性病高风险人群吸烟、饮酒和运动行为干预效果评价[J].中国慢性病预防与控制,2020,28(05):358-362.
[17] 孙晓东,贺瑛福.雌激素的脑保护作用及研究进展[J].中西医结合心血管病电子杂志,2020,8(34):35,43.
[18] Manwani B, Bentivegna K, Benashski S E, et al. Sex differences in ischemic stroke sensitivity are influenced by gonadal hormones, not by sex chromosome complement[J]. J Cereb Blood Flow Metab, 2015, 35(02): 221-229.
[19] 付棉,康琳,杨秀玲,等.脑卒中康复病例住院费用特点及影响因素分析[J].中国卫生统计,2025,42(02):267-269,273.
[20] 张毓辉,柴培培,翟铁民,等.2017年我国心脑血管疾病治疗费用核算与分析[J].中国循环杂志,2020,35(09):859-865.
相似文献/References:
[1]于保荣,许 晴,刘 卓,等.新发传染病经济负担的方法学研究[J].卫生经济研究,2017,(07):25.
[2]王晓茹,李银山,王 瑶,等.宁南地区新农合大病患者医疗费用负担分析[J].卫生经济研究,2017,(10):30.
[3]于保荣,冯映雪,江陈庆,等.肿瘤疾病经济负担与健康保险政策研究[J].卫生经济研究,2018,(04):14.
[4]冷 瑶,李燕喃,邓 晶.我国中老年糖尿病患者的疾病经济负担分析[J].卫生经济研究,2018,(10):47.
LENG Yao,LI Yan-nan,DENG Jing.Analysis of the Economic Burden of Diseases in Middle-aged and Elderly Patients with Diabetes in China[J].Journal Press of Health Economics Research,2018,(01):47.
[5]明星宇,杨 练,孙 群,等.四川省糖尿病疾病经济负担及影响因素分析[J].卫生经济研究,2019,(01):29.
MING Xing-yu,YANG Lian,SUN Qun,et al.The Disease Economic Burden and Influence of Diabetes in Sichuan Province[J].Journal Press of Health Economics Research,2019,(01):29.
[6]董 辉,汤质如,严 训,等.安徽省恶性肿瘤治疗费用分析——基于“卫生费用核算体系2011”[J].卫生经济研究,2021,38(2):58.
DONG Hui,TANG Zhi-ru,YAN Xun,et al.Analysis on Malignant Tumor Treatment Cost in Anhui Province——Based on the SHA 2011[J].Journal Press of Health Economics Research,2021,38(01):58.
[7]黎倩欣,周尚成,陈飘飘,等.深圳市糖尿病疾病经济负担研究[J].卫生经济研究,2021,38(3):63.
LI Qian-xin,ZHOU Shang-cheng,CHEN Piao-piao,et al.Study on the Economic Burden of Diabetic Diseases in Shenzhen[J].Journal Press of Health Economics Research,2021,38(01):63.
[8]李秀梅,刘 理,胡海源,等.DRG支付下脑卒中患者住院费用控制研究[J].卫生经济研究,2022,39(1):44.
LI Xiu-mei,LIU Li,HU Hai-yuan,et al.Research on the Control of Hospitalization Expenses of Stroke Patients in the Context of DRG Payment[J].Journal Press of Health Economics Research,2022,39(01):44.
[9]王佳卉,马增香.多囊卵巢综合征及其并发症的直接经济负担研究进展[J].卫生经济研究,2022,39(3):24.
WANG Jia-hui,MA Zeng-xiang.Research Progress on Direct Economic Burden of Polycystic Ovary Syndrome and Its Complications[J].Journal Press of Health Economics Research,2022,39(01):24.
[10]李福明,夏 宇,魏 艳,等.晚期非小细胞肺癌初治患者的直接非医疗成本分析[J].卫生经济研究,2022,39(10):58.
LI Fuming,XIA Yu,WEI Yan,et al.Analysis of Direct Non-medical Cost of Newly Treated Advanced Non-small Cell Lung Cancer Patients[J].Journal Press of Health Economics Research,2022,39(01):58.